BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shoaei P, Shojaei H, Shirani K. Phenotypic and Genotypic Characteristics of Clostridium difficile Isolates in Patients with Type 2 Diabetes in Iran. Infect Drug Resist 2020;13:683-90. [PMID: 32161476 DOI: 10.2147/IDR.S225829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shoaei P, Shojaei H, Siadat SD, Moshiri A, Vakili B, Yadegari S, Ataei B, Khorvash F. Gut microbiota in burned patients with Clostridioides difficile infection. Burns 2021:S0305-4179(21)00345-4. [PMID: 34924229 DOI: 10.1016/j.burns.2021.11.023] [Reference Citation Analysis]
2 Vakili B, Fateh A, Asadzadeh Aghdaei H, Sotoodehnejadnematalahi F, Siadat SD. Intestinal Microbiota in Elderly Inpatients with Clostridioides difficile Infection. Infect Drug Resist 2020;13:2723-31. [PMID: 32801806 DOI: 10.2147/IDR.S262019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
3 Brajerova M, Zikova J, Krutova M. Clostridioides difficile epidemiology in the Middle and the Far East. Anaerobe 2022;:102542. [PMID: 35240336 DOI: 10.1016/j.anaerobe.2022.102542] [Reference Citation Analysis]
4 Martínez-meléndez A, Cruz-lópez F, Morfin-otero R, Maldonado-garza HJ, Garza-gonzález E. An Update on Clostridioides difficile Binary Toxin. Toxins 2022;14:305. [DOI: 10.3390/toxins14050305] [Reference Citation Analysis]